BlackRock Health Sciences Trust (NYSE:BME) Share Price Passes Below Fifty Day Moving Average – What’s Next?

BlackRock Health Sciences Trust (NYSE:BME) crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $41.69 and traded as low as $39.26. BlackRock Health Sciences Trust shares last traded at $39.30, with a volume of 27,455 shares traded.

BlackRock Health Sciences Trust Stock Down 1.0%

The firm’s 50 day simple moving average is $41.57 and its 200 day simple moving average is $39.94.

BlackRock Health Sciences Trust Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th will be issued a $0.2621 dividend. The ex-dividend date is Monday, June 15th. This represents a c) annualized dividend and a dividend yield of 8.1%.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Northwestern Mutual Wealth Management Co. grew its stake in shares of BlackRock Health Sciences Trust by 22.2% in the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock worth $53,000 after purchasing an additional 257 shares during the last quarter. AlphaStar Capital Management LLC lifted its stake in BlackRock Health Sciences Trust by 2.2% during the fourth quarter. AlphaStar Capital Management LLC now owns 12,099 shares of the company’s stock valued at $498,000 after purchasing an additional 258 shares during the last quarter. Oppenheimer & Co. Inc. lifted its stake in BlackRock Health Sciences Trust by 5.9% during the third quarter. Oppenheimer & Co. Inc. now owns 6,715 shares of the company’s stock valued at $250,000 after purchasing an additional 373 shares during the last quarter. SOA Wealth Advisors LLC. boosted its holdings in BlackRock Health Sciences Trust by 20.3% during the third quarter. SOA Wealth Advisors LLC. now owns 2,780 shares of the company’s stock worth $103,000 after buying an additional 469 shares in the last quarter. Finally, HBK Sorce Advisory LLC boosted its holdings in BlackRock Health Sciences Trust by 3.8% during the fourth quarter. HBK Sorce Advisory LLC now owns 13,160 shares of the company’s stock worth $554,000 after buying an additional 476 shares in the last quarter.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.